At Microbion, we are developing a new class of therapeutic drugs to tackle the unmet needs of rare, chronic, and serious diseases. Our lead drug candidate, pravibismane, is a first-in-class therapeutic with a novel triad of activities: anti-infective, antibiofilm, and anti-inflammatory. These synergistic properties uniquely position pravibismane to address conditions where conventional treatments often fail.
We are advancing multiple pravibismane formulations through clinical development, focusing on indications with significant unmet needs:
- Topical pravibismane for diabetic foot ulcers/infections: Phase 3 studies planned for 2025
- Local/surgical pravibismane for orthopedic infections: Phase 2a studies completed
- Inhaled pravibismane for pulmonary diseases including Nontuberculous mycobacteria lung infections: Ready for first-in-human Phase 1 studies
Pravibismane has been granted FDA Qualified Infectious Disease Product (QIDP), Fast Track, and Orphan Drug designations, underscoring its disruptive potential.
To date, pravibismane development has been supported by over $22M in grants awarded from leading organizations, including the U.S. Department of Defense, NIH, CARB-X, and the Cystic Fibrosis Foundation.
We are actively seeking strategic licensing and development partners to advance Phase 3 trials, explore new indications (e.g., immunomodulation and inflammation), and bring pravibismane to patients worldwide.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 5 West Mendenhall Street,
- Phone
- 8778058377
- in****@****orp.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- microbioncorp.com
- HQ
- Bozeman, Montana
Microbion Corporation Questions
Microbion Corporation's helpline number is 8778058377
Microbion Corporation's website is microbioncorp.com
Microbion Corporation's LinkedIn profile is https://www.linkedin.com/company/microbion-corporation
Microbion Corporation has
15 employees.
View email and phone details for 15
employees at Microbion Corporation.
Microbion Corporation's industry is
Pharmaceutical Manufacturing
Microbion Corporation's top competitors are
Inimmune,
Fmrk Diagnostic Technologies,
Aspect Biosystems,
Sustained Therapeutics,
Ubc-Bcit Biotechnology Club,
Nanovalent Pharmaceuticals, Inc.,
Alercell,
Zymeworks Inc.,
Bold Therapeutics Inc.,
Microbion.
Microbion Corporation's support email address is info@microbioncorp.com
Microbion Corporation's categories are Pharmaceutical Manufacturing
Microbion Corporation's founding year is 2000
